Raju G C
Department of Pathology, National University of Singapore.
Histopathology. 1988 Apr;12(4):437-43. doi: 10.1111/j.1365-2559.1988.tb01958.x.
It has been suggested that cytokeratin CAM 5.2 is a useful marker to indicate malignant transformation and invasive potential in cervical neoplasia. In this study we examined normal ectocervical epithelium, endocervical squamous metaplasia, cervical intra-epithelial neoplasia (CIN) and invasive carcinoma by the indirect immunoperoxidase method using commercially available CAM 5.2. Positive staining was seen in 12 of 42 (28%) invasive carcinomas and in 2 of 26 specimens of CIN III. No positive staining was observed in any case of CIN II (22 specimens), CIN I (19), squamous metaplasia (21) or normal ectocervical epithelium (16). These results suggest that although CAM 5.2 expression is found in only 28% of cervical squamous carcinoma, it is highly specific for malignant transformation of cervical squamous epithelium. In view of its potential diagnostic value in doubtful cases of CIN III and squamous cell carcinoma, the specificity and sensitivity of CAM 5.2 expression in cervical neoplasia need to be examined in other laboratories under various processing schedules.
有人提出细胞角蛋白CAM 5.2是一种有用的标志物,可指示宫颈肿瘤的恶性转化和侵袭潜能。在本研究中,我们使用市售的CAM 5.2,通过间接免疫过氧化物酶法检查了正常宫颈外膜上皮、宫颈内膜鳞状化生、宫颈上皮内瘤变(CIN)和浸润癌。42例浸润癌中有12例(28%)呈阳性染色,26例CIN III标本中有2例呈阳性染色。在任何CIN II(22例标本)、CIN I(19例)、鳞状化生(21例)或正常宫颈外膜上皮(16例)病例中均未观察到阳性染色。这些结果表明,虽然仅在28%的宫颈鳞状癌中发现CAM 5.2表达,但它对宫颈鳞状上皮的恶性转化具有高度特异性。鉴于其在CIN III和鳞状细胞癌可疑病例中的潜在诊断价值,需要在其他实验室按照各种处理方案检查CAM 5.2在宫颈肿瘤中表达的特异性和敏感性。